Publication | Closed Access

The ameliorative effects of thymoquinone and beta-aminoisobutyric acid on streptozotocin-induced diabetic cardiomyopathy

Metabolic SyndromeHeart FailureMedicinePhysiologyDiabetesDiabetic NeuropathyStreptozotocin-induced Diabetic CardiomyopathyAmeliorative EffectsDiabetes MellitusPharmacologyBeta-aminoisobutyric AcidHealth Sciences